MedCap Sees Q4 EBITA At SEK 71 Mln, Down 23% Vs Year Ago
Reuters
17 Jan
Jan 17 (Reuters) - MedCap AB :: *SAID ON THURSDAY ESTIMATES THAT Q4 REVENUES WILL AMOUNT TO SEK 474 MLN, UP 4 % VS YEAR AGO *Q4 EBITA IS EXPECTED TO AMOUNT TO SEK 71 MLN, DOWN 23% VS YEAR AGO *Q4 ADJUSTED EBITA IS EXPECTED TO AMOUNT TO SEK 67 MLN, DOWN 27% VS YEAR AGO *SAID SIGNIFICANTLY LOWER EARNINGS IN BUSINESS AREA SPECIALTY PHARMA ARE DUE TO INCREASED COMPETITION ON BRITISH MARKET FOR MELATONIN *SAID MARGIN IS IMPACTED E.G. BY PRODUCT MIX AND INVENTORY WRITE-DOWNS
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.